Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Fluorescent Proteins Illuminating Biomedical Research

27.01.2009
Remarkable new tools that spotlight individual cellular molecules are transforming biomedical research. Scientists at the Gruss Lipper Biophotonics Center at the Albert Einstein College of Medicine of Yeshiva University have spearheaded their use in a series of papers, including one published today in the online version of Nature Methods.

These new tools are photoactivatable fluorescent proteins (PAFPs) and other advanced fluorescent proteins (FPs), several of which have been developed by Vladislav Verkhusha, Ph.D., associate professor of anatomy & structural biology at Einstein, and a member of the Biophotonics Center.

PAFPs and FPs allow scientists to noninvasively visualize the structures and processes in living cells at the molecular level. It is now possible, for example, to follow cancer cells as they seek out blood vessels and spread throughout the body or to watch how cells manage intracellular debris, preventing premature aging.

These new fluorescent proteins add considerably to the biomedical imaging revolution started by the 1992 discovery that the gene for a green fluorescent protein (GFP) found in a jellyfish could be fused to any gene in a living cell. When the target gene is expressed, GFP lights up (fluoresces), creating a visual marker of gene expression and protein localization, via light (optical) microscopy. Three scientists won The 2008 Nobel Prize in Chemistry for their GFP-related discoveries. Fluorescent proteins of other colors have since been found in marine organisms such as corals.

While this form of imaging is invaluable, it is limited by the inherent nature of optical microscopy, which cannot image details of objects smaller than 200 nanometers or so. However, many cellular structures, which could hold the key to managing or curing disease, are a small fraction of that size — just a few nanometers or more.

Using a sophisticated combination of lasers, computers, and highly sensitive digital cameras, scientists have been able to surmount the barriers of optical imaging. The first generation of these new imaging devices, collectively known as super-resolution (SR) fluorescence microscopes, were able to capture images as small as 15 to 20 nanometers — the scale of single molecules. But this could be done only in non-living cells. The addition of PAFPs, more versatile versions of FPs, made it possible to do real-time SR fluorescence microscopy in living cells. Last month, Nature Methods selected SR fluorescence microscopy as the 2008 Method of the Year.

Dr. Verkhusha has developed a variety of PAFPs and FPs for use in imaging mammalian cells, expanding the applications of fluorescence microscopy. Among these are PAFPs that can be turned on and off with a pulse of light, FPs that can fluoresce in different colors, and FPs that have better resolution for deep-tissue imaging.

Most recently, Dr. Verkhusha developed a red PAFP called PAmCherry1, which has faster photoactivation, improved contrast, and better stability compared to other PAFPs of its type. “PAmCherry1 will allow improvements in several imaging techniques, notably two-color SR fluorescence microscopy, in which two different molecules or two biological processes can be viewed simultaneously in a single cell,” explains Dr. Verkhusha. The findings were published today in the online version of Nature Methods.

Several studies have employed Dr. Verkhusha’s PAFPs, revealing new insights into a variety of biological processes. For example, one of his PAFPs was used to capture the first nanoscale images of the orientation of molecules within biological structures. “Such images could be useful in studying protein-protein interactions, the growth and collapse of intracellular structures, and many other biological questions,” says Dr. Verkhusha. The results were published in November 2008 in Nature Methods.

In yet another Nature Methods study, also published in November 2008, Dr. Verkhusha contributed a novel PAFP to a new method of viewing individual breast cancer cells for several days at a time, providing new details on how cancer cells invade surrounding tissue and reach blood vessels, a process called metastasis. “Mapping the fate of tumor cells in different regions of a tumor was not possible before the development of the photoswitching technology," explains John Condeelis, Ph.D., co-chair and professor of anatomy and structural biology and co-director of the Gruss Lipper Biophotonics Center.

In addition, Dr. Verkhusha has developed new types of fluorescent proteins for use in conventional fluorescent microscopy. These new fluorescent proteins, called fluorescent timers (FTs), can change their color from blue to red over a matter of hours. “These FTs will enable scientists to study the trafficking of cellular proteins and to provide accurate insight into the timing of intracellular processes, such as activation or inhibition of gene expression or protein synthesis,” says Dr. Verkhusha.

Together with another Einstein scientist, Ana Maria Cuervo, M.D., Ph.D., associate professor of developmental & molecular biology, anatomy & structural biology, and medicine, Dr. Verkhusha employed the FTs to demonstrate for the first time how a protein called LAMP-2A, which scavenges cellular debris, is transported to intracellular organelles called lysosomes, where the debris is digested. Understanding this process, which maintains the health of cells and organs, may lead to treatments to keep elderly people's organs in prime condition. The findings were published in the January 11 issue of Nature Chemical Biology.

About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University is one of the nation’s premier centers for research, medical education and clinical investigation. It is the home to some 2,000 faculty members, 750 M.D. students, 350 Ph.D. students (including 125 in combined M.D./Ph.D. programs) and 380 postdoctoral investigators. Last year, Einstein received more than $130 million in support from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Through its extensive affiliation network involving five hospital centers in the Bronx, Manhattan and Long Island – which includes Montefiore Medical Center, Einstein’s officially designated University Hospital – the College runs one of the largest post-graduate medical training program in the United States, offering approximately 150 residency programs to more than 2,500 physicians in training.

Michael Heller | Newswise Science News
Further information:
http://www.aecom.yu.edu

More articles from Life Sciences:

nachricht Old drug may be key to new antibiotics
23.09.2014 | McMaster University

nachricht Can tapioca replace corn as the main source for starch sweeteners?
23.09.2014 | Mary Ann Liebert, Inc./Genetic Engineering News

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Big Data: Herausforderung in der Wissenschaft

23.09.2014 | Veranstaltungen

Lösungen für Megatrends: ProcessNet-Jahrestagung und Jahrestagung der Biotechnologen in Aachen

22.09.2014 | Veranstaltungen

Englisch ab Klasse 1 oder 3? Never mind!

22.09.2014 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Wie Gebirge Meeresströmungen beeinflussen

23.09.2014 | Geowissenschaften

Wie die Puppenhand zum Körperteil wird

23.09.2014 | Medizin Gesundheit

Elektronik für die Energieversorgung: Strategische Kooperation zwischen Siemens und Fraunhofer IISB

23.09.2014 | Energie und Elektrotechnik